# If you had invested $1,000 in AstraZeneca PLC (AZN)

Source: https://www.equity-rank.com/if-you-invested/AZN

10 years ago (Mon, Nov 7, 2016), $1,000 in AZN grew to **$4,458** by Fri, Nov 6, 2026 with dividends reinvested ($3,342 on price alone). The same $1,000 in SPY grew to $4,042. Along the way AZN fell as much as -27.9% from a high. Past results do not tell you what happens next.

| Invested | AZN, dividends reinvested | Per year | Worst fall | SPY | SPY per year |
| --- | --- | --- | --- | --- | --- |
| 1 year ago | $1,144 | +14.4% | -25.3% | $1,109 | +10.9% |
| 3 years ago | $1,560 | +16.0% | -27.9% | $1,750 | +20.5% |
| 5 years ago | $1,660 | +10.7% | -27.9% | $1,677 | +10.9% |
| 10 years ago | $4,458 | +16.1% | -27.9% | $4,042 | +15.0% |

Today: model fair value $198.00 against a $186.43 price (gap +6.2%).

Split-adjusted closes; 21 cash dividends reinvested on their ex-dividend dates, before taxes and costs. SPY on its total-return price. Data as of Fri, Nov 6, 2026.

[Full AZN valuation](https://www.equity-rank.com/stocks/AZN) · [Other companies](https://www.equity-rank.com/if-you-invested)

---

Fair value is a model estimate under stated assumptions — not a price target, not a prediction, and not a recommendation. This page is research information, not investment advice. Equity Rank is not a registered investment adviser.